Global Drug formulations Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
Methyldopa Methyldopa and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
Imidazoline receptor agonists Imidazoline receptor agonists and its peer markets - Chromatography, |
Upcoming |
|
Sulfonium derivatives Sulfonium derivatives and its peer markets - Chromatography Instruments, |
Upcoming |
|
Secondary and tertiary amines Secondary and tertiary amines and its peer markets - Chromatography, |
Upcoming |
|
Bisquaternary ammonium compounds Bisquaternary ammonium compounds and its peer markets - Chromatography Instruments, |
Upcoming |
|
Alpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonists and its peer markets - Proteomics, |
Upcoming |
|
Guanidine derivatives Guanidine derivatives and its peer markets - Immunoassay, |
Upcoming |
|
Thiazide derivatives Thiazide derivatives and its peer markets - Chromatography, |
Upcoming |
|
Hydrazinophthalazine derivatives Hydrazinophthalazine derivatives and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
Pyrimidine derivatives Pyrimidine derivatives and its peer markets - Wireless Health, |
Upcoming |
|
Nitroferricyanide derivatives Nitroferricyanide derivatives and its peer markets - Immunoassay, |
Upcoming |
|
Pinacidil Pinacidil and its peer markets - Digital Pathology, |
Upcoming |
|
Alkaloids, excl. rauwolfia Alkaloids, excl. rauwolfia and its peer markets - Digital Pathology, |
Upcoming |
|
Tyrosine hydroxylase inhibitors Tyrosine hydroxylase inhibitors and its peer markets - Wireless Health, |
Upcoming |
|
MAO inhibitors MAO inhibitors and its peer markets - Serotonin antagonists, |
Upcoming |
|
Serotonin antagonists Serotonin antagonists and its peer markets - Proteomics, |
Upcoming |
|
Rauwolfia alkaloids and diuretics in combination Rauwolfia alkaloids and diuretics in combination and its peer markets - Proteomics, |
Upcoming |
|
Methyldopa and diuretics in combination Methyldopa and diuretics in combination and its peer markets - Hydrazinophthalazine derivatives and diuretics, |
Upcoming |
|
Imidazoline receptor agonists in combination with diuretics Imidazoline receptor agonists in combination with diuretics and its peer markets - Chromatography, |
Upcoming |
|
Alpha-adrenoreceptor antagonists and diuretics Alpha-adrenoreceptor antagonists and diuretics and its peer markets - Imidazoline receptor agonists in combination with... |
Upcoming |
Drug formulations





